HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stuart, P. M. Articles by Ferguson, T. A. Search for Related Content PubMed PubMed Citation Articles by Stuart, P. M. Articles by Ferguson, T. A.

FasL-Fas Interactions Regulate Neovascularization in the Cornea

¹From the Departments of Ophthalmology and Visual Sciences, ²Molecular Microbiology and Pathogenesis, and ³Pathology, Washington University Medical School, St. Louis, Missouri.

PURPOSE. Neovascularization of the avascular cornea is a significant problem associated with many corneal diseases. Because Fas ligand (FasL) is highly expressed in the cornea, the role of this molecule in controlling corneal neovascularization was examined in this study.

METHODS. C57BL/6(B6), FasL (CD95L)-deficient B6-gld, and Fas (CD95)-deficient B6-lpr mice were subjected to the suture model of neovascularization. Corneas were evaluated for neovascularization and representative samples subjected to immunohistochemical analysis for expression of Fas antigen and CD31 (platelet-endothelial cell adhesion molecule [PECAM-1]) on vessels that were present in the tissue. Corneas were also explanted and placed in collagen gel cultures to test the ability of anti-Fas antibody to prevent vessel extension from explanted corneas.

RESULTS. Immunohistochemical data demonstrated that quiescent vessels express CD31 alone, whereas vessels that penetrate the cornea coexpressed both the Fas antigen and CD31. A significant increase was observed in neovascularization in FasL-deficient B6-gld corneas compared with B6 corneas, and new vessel growth in both B6 and B6-gld was inhibited by anti-Fas antibody. Whereas Fas-deficient B6-lpr corneas displayed significantly less neovascularization than normal B6, B6-lpr mice express Fas on growing vessels. In corneal explant cultures, vessel growth from B6 and lpr mice corneas was inhibited by anti-Fas antibody, confirming functional Fas expression in B6-lpr mice.

CONCLUSIONS. These data indicate that FasL is an important factor in controlling corneal neovascularization.

This article has been cited by other articles:

				R. Cao, M. A. Bjorndahl, M. I. Gallego, S. Chen, P. Religa, A. J. Hansen, and Y. Cao Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action Blood, May 1, 2006; 107(9): 3531 - 3536. [Abstract] [Full Text] [PDF]

				P. M. Stuart, B. Summers, J. E. Morris, L. A. Morrison, and D. A. Leib CD8+ T cells control corneal disease following ocular infection with herpes simplex virus type 1 J. Gen. Virol., July 1, 2004; 85(7): 2055 - 2063. [Abstract] [Full Text] [PDF]

				H. Osawa, K. Maruyama, and J. W. Streilein CD95 Ligand Expression on Corneal Epithelium and Endothelium Influences the Fates of Orthotopic and Heterotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1908 - 1915. [Abstract] [Full Text] [PDF]

				P. M. Stuart, F. Pan, X. Yin, Z. Haskova, S. Plambeck, and T. A. Ferguson Effect of Metalloprotease Inhibitors on Corneal Allograft Survival Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1169 - 1173. [Abstract] [Full Text] [PDF]

				M. A. Amin, O. V. Volpert, J. M. Woods, P. Kumar, L. A. Harlow, and A. E. Koch Migration Inhibitory Factor Mediates Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol Kinase Circ. Res., August 22, 2003; 93(4): 321 - 329. [Abstract] [Full Text] [PDF]